NEW YORK, Jan. 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.  Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Physicians Realty Trust (NYSE: DOC) click to participate
    Physicians Realty Trust is set to merge with Healthpeak Properties, a transaction that will result in Physicians Realty Trust shareholders owning about 23% of the new, combined entity.

  • Battalion Oil Corporation (NYSE: BATL) click to participate
    Battalion Oil has entered into a buyout agreement with Fury Resources. As per the agreement's terms, Battalion shareholders are set to receive a payment of $9.80 per share in cash.

  • Kaman Corp. (NYSE: KAMN) click to participate
    Kaman has reached a deal to be quired by Arcline Investment Management, L.P. In this deal, each Kaman shareholder will be paid $46.00 per share in a cash transaction.

  • Inhibrx, Inc. (NASDAQ: INBX) click to participate
    Sanofi is set to acquire Inhibrx, with Inhibrx shareholders receiving $30.00 per share in cash. Additionally, Inhibrx shareholders will get a contingent value right of $5.00, subject to reaching a regulatory milestone, and 0.25 shares in a new public company holding Inhibrx's non-INBRX-101 assets.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients.  Shareholders are advised to act promptly, as legal rights may be time-sensitive.  For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-doc-batl-kamn-and-inbx-investors-to-contact-law-firm-302045811.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

Inhibrx (NASDAQ:INBX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Inhibrx Charts.
Inhibrx (NASDAQ:INBX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Inhibrx Charts.